日本の止血剤市場レポート：製品、剤形、用途、地域別、2025年～2033年

日本の止血剤市場の市場規模は2024年に2億2,030万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに3億6,260万米ドルに達し、2025年から2033年にかけて5.1％の成長率（CAGR）を示すと予測しています。心血管疾患、がん、糖尿病などの慢性疾患の有病率の上昇と外科的介入の必要性の高まりが市場を牽引しています。

本レポートで扱う主な質問

• 日本の止血剤市場はこれまでどのように推移し、今後どのように推移するのか？
• COVID-19の日本の止血剤市場への影響は？
• 日本の止血剤市場の製品別の内訳は？
• 日本の止血剤市場の剤形別の内訳は？
• 日本の止血剤市場の用途別の内訳は？
• 日本の止血剤市場のバリューチェーンにはどのような段階がありますか？
• 日本の止血剤の主な促進要因と課題は何か？
• 日本の止血剤市場の構造と主要プレーヤーは？
• 日本の止血剤市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
• 市場推定
• 調査手法

第3章 エグゼクティブサマリー

第4章 日本の止血剤市場：イントロダクション

• 概要
• 市場力学
• 業界動向
• 競合情報

第5章 日本の止血剤市場情勢

• 過去および現在の市場動向（2019年～2024年）
• 市場予測（2025-2033）

第6章 日本の止血剤市場：製品別の内訳

• トロンビンベース
• 併用ベース
• 酸化再生セルロースベース
• ゼラチンベース
• コラーゲンベース

第7章 日本の止血剤市場：剤形別の内訳

• マトリックスおよびゲル止血剤
• シートおよびパッドの止血剤
• スポンジ止血剤
• 粉末止血剤

第8章 日本の止血剤市場：用途別の内訳

• 整形外科
• 一般外科
• 神経外科
• 心臓血管外科
• 再建手術
• 婦人科手術
• その他

第9章 日本の止血剤市場：競合情勢

• 概要
• 市場構造
• 市場プレーヤーのポジショニング
• 主要成功戦略
• 競合ダッシュボード
• 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の止血剤市場：業界分析

• 促進要因・抑制要因・機会
• ポーターのファイブフォース分析
• バリューチェーン分析

第12章 付録

Japan hemostats market size reached USD 220.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 362.6 Million by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The escalating prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes, along with the rising need for surgical interventions, is driving the market.

Hemostats are surgical instruments used to control bleeding during medical procedures. They consist of two hinged, scissor-like handles with serrated jaws at the working end. These jaws can be locked in place to grip blood vessels or tissues, effectively clamping them shut to prevent further bleeding. Hemostats are commonly used in surgeries, both minor and major, as well as in various medical settings like emergency rooms and dental offices. The key function of hemostats is to provide precise and temporary occlusion of blood vessels, allowing healthcare professionals to work safely and effectively without excessive bleeding hindering their procedures. They come in various sizes and designs, with straight or curved tips, to accommodate different surgical needs. Hemostats can also be used to grasp and manipulate delicate tissues during surgery. Their versatility makes them invaluable tools in the medical field, aiding in achieving hemostasis and ensuring successful surgical outcomes while minimizing the risk of complications due to excessive bleeding.

Japan Hemostats Market Trends:

Several key factors are driving growth in the hemostats market. Firstly, the increasing number of surgical procedures in Japan has created a robust demand for hemostatic agents. As surgeries become more advanced and minimally invasive, the need for effective hemostats to control bleeding during these procedures has surged. Furthermore, the aging population is contributing significantly to market expansion. With a growing elderly demographic, the incidence of chronic diseases and surgeries, such as cardiovascular and orthopedic procedures, has risen, further propelling the demand for hemostatic products. Additionally, advancements in hemostatic technologies have played a pivotal role in market expansion. Innovative products with enhanced efficacy and safety profiles have gained traction among healthcare professionals, driving market growth. Furthermore, the increasing awareness of hemostatic products and their benefits among both healthcare providers and patients has positively influenced market dynamics. Moreover, the market is witnessing a surge in investment in R&D activities, fostering the introduction of novel hemostatic solutions. Collaborations between pharmaceutical companies and research institutions are pushing the boundaries of innovation, creating new opportunities in the hemostats market. These interconnected drivers are fueling the regional hemostats market's continued growth and are expected to shape its trajectory in the coming years.

Japan Hemostats Market Segmentation:

Product Insights:

• Thrombin Based
• Combination Based
• Oxidized Regenerated Cellulose Based
• Gelatin Based
• Collagen Based

Formulation Insights:

• Matrix and Gel Hemostats
• Sheet and Pad Hemostats
• Sponge Hemostats
• Powder Hemostats

Application Insights:

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

• How has the Japan hemostats market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan hemostats market?
• What is the breakup of the Japan hemostats market on the basis of product?
• What is the breakup of the Japan hemostats market on the basis of formulation?
• What is the breakup of the Japan hemostats market on the basis of application?
• What are the various stages in the value chain of the Japan hemostats market?
• What are the key driving factors and challenges in the Japan hemostats?
• What is the structure of the Japan hemostats market and who are the key players?
• What is the degree of competition in the Japan hemostats market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Hemostats Market - Introduction

• 4.1 Overview
• 4.2 Market Dynamics
• 4.3 Industry Trends
• 4.4 Competitive Intelligence

5 Japan Hemostats Market Landscape

• 5.1 Historical and Current Market Trends (2019-2024)
• 5.2 Market Forecast (2025-2033)

6 Japan Hemostats Market - Breakup by Product

• 6.1 Thrombin Based
  • 6.1.1 Overview
  • 6.1.2 Historical and Current Market Trends (2019-2024)
  • 6.1.3 Market Forecast (2025-2033)
• 6.2 Combination Based
  • 6.2.1 Overview
  • 6.2.2 Historical and Current Market Trends (2019-2024)
  • 6.2.3 Market Forecast (2025-2033)
• 6.3 Oxidized Regenerated Cellulose Based
  • 6.3.1 Overview
  • 6.3.2 Historical and Current Market Trends (2019-2024)
  • 6.3.3 Market Forecast (2025-2033)
• 6.4 Gelatin Based
  • 6.4.1 Overview
  • 6.4.2 Historical and Current Market Trends (2019-2024)
  • 6.4.3 Market Forecast (2025-2033)
• 6.5 Collagen Based
  • 6.5.1 Overview
  • 6.5.2 Historical and Current Market Trends (2019-2024)
  • 6.5.3 Market Forecast (2025-2033)

7 Japan Hemostats Market - Breakup by Formulation

• 7.1 Matrix and Gel Hemostats
  • 7.1.1 Overview
  • 7.1.2 Historical and Current Market Trends (2019-2024)
  • 7.1.3 Market Forecast (2025-2033)
• 7.2 Sheet and Pad Hemostats
  • 7.2.1 Overview
  • 7.2.2 Historical and Current Market Trends (2019-2024)
  • 7.2.3 Market Forecast (2025-2033)
• 7.3 Sponge Hemostats
  • 7.3.1 Overview
  • 7.3.2 Historical and Current Market Trends (2019-2024)
  • 7.3.3 Market Forecast (2025-2033)
• 7.4 Powder Hemostats
  • 7.4.1 Overview
  • 7.4.2 Historical and Current Market Trends (2019-2024)
  • 7.4.3 Market Forecast (2025-2033)

8 Japan Hemostats Market - Breakup by Application

• 8.1 Orthopedic Surgery
  • 8.1.1 Overview
  • 8.1.2 Historical and Current Market Trends (2019-2024)
  • 8.1.3 Market Forecast (2025-2033)
• 8.2 General Surgery
  • 8.2.1 Overview
  • 8.2.2 Historical and Current Market Trends (2019-2024)
  • 8.2.3 Market Forecast (2025-2033)
• 8.3 Neurological Surgery
  • 8.3.1 Overview
  • 8.3.2 Historical and Current Market Trends (2019-2024)
  • 8.3.3 Market Forecast (2025-2033)
• 8.4 Cardiovascular Surgery
  • 8.4.1 Overview
  • 8.4.2 Historical and Current Market Trends (2019-2024)
  • 8.4.3 Market Forecast (2025-2033)
• 8.5 Reconstructive Surgery
  • 8.5.1 Overview
  • 8.5.2 Historical and Current Market Trends (2019-2024)
  • 8.5.3 Market Forecast (2025-2033)
• 8.6 Gynecological Surgery
  • 8.6.1 Overview
  • 8.6.2 Historical and Current Market Trends (2019-2024)
  • 8.6.3 Market Forecast (2025-2033)
• 8.7 Others
  • 8.7.1 Historical and Current Market Trends (2019-2024)
  • 8.7.2 Market Forecast (2025-2033)

9 Japan Hemostats Market - Competitive Landscape

• 9.1 Overview
• 9.2 Market Structure
• 9.3 Market Player Positioning
• 9.4 Top Winning Strategies
• 9.5 Competitive Dashboard
• 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

• 10.1 Company A
  • 10.1.1 Business Overview
  • 10.1.2 Product Portfolio
  • 10.1.3 Business Strategies
  • 10.1.4 SWOT Analysis
  • 10.1.5 Major News and Events
• 10.2 Company B
  • 10.2.1 Business Overview
  • 10.2.2 Product Portfolio
  • 10.2.3 Business Strategies
  • 10.2.4 SWOT Analysis
  • 10.2.5 Major News and Events
• 10.3 Company C
  • 10.3.1 Business Overview
  • 10.3.2 Product Portfolio
  • 10.3.3 Business Strategies
  • 10.3.4 SWOT Analysis
  • 10.3.5 Major News and Events
• 10.4 Company D
  • 10.4.1 Business Overview
  • 10.4.2 Product Portfolio
  • 10.4.3 Business Strategies
  • 10.4.4 SWOT Analysis
  • 10.4.5 Major News and Events
• 10.5 Company E
  • 10.5.1 Business Overview
  • 10.5.2 Product Portfolio
  • 10.5.3 Business Strategies
  • 10.5.4 SWOT Analysis
  • 10.5.5 Major News and Events

11 Japan Hemostats Market - Industry Analysis

• 11.1 Drivers, Restraints, and Opportunities
  • 11.1.1 Overview
  • 11.1.2 Drivers
  • 11.1.3 Restraints
  • 11.1.4 Opportunities
• 11.2 Porters Five Forces Analysis
  • 11.2.1 Overview
  • 11.2.2 Bargaining Power of Buyers
  • 11.2.3 Bargaining Power of Suppliers
  • 11.2.4 Degree of Competition
  • 11.2.5 Threat of New Entrants
  • 11.2.6 Threat of Substitutes
• 11.3 Value Chain Analysis

12 Appendix